Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
Frontiers in Cardiovascular Medicine|April 9, 2020
WorldwIde SurvEy on Clinical and Anatomical Factors Driving the Choice of Transcatheter Aortic Valve pRosthesesLuigi Biasco, Enrico Cerrato, Gregorio Tersalvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxelCarlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, et al.
NPJ Breast Cancer|December 5, 2018
Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancerCristina Guarducci, Martina Bonechi, Matteo Benelli, et al.
Anticancer Research|August 15, 2002
3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot studyAntonio Fabiano Ferreira Filho, John Crown, Fatima Cardoso, et al.
Clinical Breast Cancer|October 28, 2008
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278)Valentina Guarneri, Antonio Frassoldati, Paolo Bruzzi, et al.
Breast (Edinburgh, Scotland)|June 15, 2020
Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trialZhuoxin Sun, Samuel M Niman, Olivia Pagani, et al.
NPJ Breast Cancer|January 25, 2019
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancerStephen Johnston, Miguel Martin, Angelo Di Leo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2017
Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter PopulationChristopher D Hart, Alessia Vignoli, Leonardo Tenori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2020
Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass IndexChristine Desmedt, Marco Fornili, Florian Clatot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
TransCONFIRM: Identification of a Genetic Signature of Response to Fulvestrant in Advanced Hormone Receptor-Positive Breast CancerRinath Jeselsohn, William T Barry, Ilenia Migliaccio, et al.
Pageof 18